Clinical Trial Update: Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating H1-receptor antagonists for irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• H1-receptor antagonists

Snippet

Sponsor: KU Leuven | Conditions: Irritable Bowel Syndrome | Phase 4 | Status: COMPLETED